跳至主要内容
临床试验/SLCTR/2013/006
SLCTR/2013/006
已完成
未知

A randomized, double blind, controlled clinical trial of S-Amlodipine versus conventional Amlodipine, to compare the incidence of leg edema and antihypertensive efficacy in patients with hypertension

Emcure Pharmaceuticals Limited0 个研究点待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Hypertension, leg oedema
发起方
Emcure Pharmaceuticals Limited
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Interventional

研究者

入排标准

入选标准

  • 30\-64 years of age • Diagnosed essential hypertension with either systolic BP \> 140mmHg or diastolic BP \> 90 mmHg or both while in the seated position • On beta blockers and ACE inhibitor /Angiotensin receptor blocker for at least 4 weeks • Consenting and willing to comply with study protocol

排除标准

  • Known hypersensitivity to amlodipine, calcium channel blockers or to any ingredients of the test/reference medication • Patients on calcium channel blockers or antihypertensive therapy other than ACE inhibitors or Angiotensin receptor blockers • Secondary hypertention • Clinical diagnosis of resistant or malignant hypertension • History of myocardial infarction or congestive cardiac failure • PTCA, CABG, cerebrovascular accident, or TIA in last 6 months • Diagnosed cardiac arrhythmias and/or any other abnormality on ECG • Significant respiratory /liver/ kidney/neurological diseases/ coagulation disorders • Metabolic or endocrine disorders (except Type 2 diabetes mellitus • Type 2 diabetes mellitus taking insulin or oral hypoglycemic drugs other than metformin or sulfonylurea or patients on more than one sulfonylurea • Pregnant and lactating women or women in the reproductive age group not practicing effective means of contraception. • Known alcohol or drug abuse
  • Any condition that, in the opinion of the investigator, does not justify the patient’s inclusion in the study.

结局指标

主要结局

未指定

相似试验